News - Appointments

Microbiotica Ltd has made two appointments to its management team.

The biotech and medtech entrepreneur Philippe Dro has joined Scenic Biotech BV of the Netherlands as independent chairman of the board of directors.

NOXXON Pharma NV has appointed Jose Saro as chair of its newly formed scientific advisory board which will provide strategic advice on its programmes for cancer.

The British cancer diagnostics company, Biofidelity Ltd, has named Wendy Levin as chief medical officer, based in the US.

Gerard Short has joined VarmX BV of the Netherlands as chief medical officer.

The Spanish pharma company Accure Therapeutics has announced the appointment of Rossella Medori as its chief medical officer.

Oxurion NV of Belgium has appointed Alan Stitt as chief scientific officer to help it develop ophthalmic therapies, with a focus on diabetic macular oedema.

T-knife GmbH, which is developing adoptive T cell therapies, has appointed Thomas Soloway as chief executive, and Camille Landis as chief business officer and chief financial officer, ahead of its transition from a discovery to a clinical-stage company.

UK-based Domainex Ltd has made two appointments to its executive team as it expands its service business to the global biopharmaceutical industry.

Richard Francis, former chief executive of the Sandoz division of Novartis, has been named CEO of the gene therapy company Purespring Therapeutics Ltd, effective 1 February. Purespring was launched in November 2020 to develop AAV gene therapies for kidney disease.